Current Report Filing (8-k)
April 27 2017 - 12:13PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): April 26
th
, 2017
MEDICAL
INNOVATION HOLDINGS, INC.
(Exact
name of registrant as specified in its charter)
|
Colorado
|
|
000-27211
|
|
84-1469319
|
|
(State
or Other Jurisdiction
|
|
(Commission
|
|
(I.R.S.
Employer
|
|
of
Incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
5805
State Bridge Road, Suite G-328, Duluth, Georgia 30097
(Address of Principal Executive Offices) (Zip Code)
(866)
883-3793
(Registrant’s telephone number, including area code)
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
SECTION
8 — OTHER EVENTS
|
Item
8.01
|
MIHI
Goes Global Entering New Markets with Letter of Intent to acquire BBVI, an International Marketer and Consultancy.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
|
Medical
Innovation Holdings, Inc.
|
|
|
|
|
|
|
By:
|
/s/
Arturo Jake Sanchez
|
|
|
Name:
|
Arturo “Jake”
Sanchez
|
|
|
Title:
|
CEO
|
Date:
April 27
th
, 2017
INDEX
TO EXHIBITS
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
99.1
|
|
Press Release
|